2026 NPPES data Hematology & Oncology Physician NPI 1538508965 M.D.
Verify on CMS →

Daniel Sonnenburg, M.D.

Hematology & Oncology Physician in Indianapolis, Indiana.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 307 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
62%
generic claims · 38% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$9.2K
56 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Daniel Sonnenburg, M.D. filed 1,574 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Indianapolis, Indiana, prescribing 62% generic.

2K
Part D claims, 2024
62%
generic prescribing
Likely
board-certified (heuristic)
≥81st
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Daniel Sonnenburg, M.D.

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1538508965), first enumerated 06/19/2013.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,574 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $9.2K in reported industry payments (56 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1538508965 · Hematology & Oncology Physician

NPI-10 · ENUM-MID · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1538508965
  • ENUM-MID 2013
  • TAX-MID 12K Hematology &
  • RX-MID 1,574
  • BOOK-THIN 176 in Indiana
  • PHOTO-ENUM Amy Pratt, D.O. · 2013

Daniel Sonnenburg, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

1,574 ≥ 81st percentile 81% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). Below this entry. 1,000–1,200: 33,612 prescribers (2%). Below this entry. 1,200–1,400: 27,889 prescribers (2%). Below this entry. 1,400–1,600: 23,183 prescribers (2%). This entry sits in this band. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Daniel Sonnenburg, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Daniel Sonnenburg, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/19/2013

NPI 1538508965

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

1,574 78% vs specialty avg

2024 prescription claims

Specialty avg: 885

Specialty distribution in Indiana

How Hematology & Oncology Physician compares to other specialties among Indiana providers

Indiana providers
Behavior Technician14.3%Student in an Organized Heal…4.8%Pharmacist4.3%Clinical Social Worker4.2%Family Nurse Practitioner4.2%Mental Health Counselor4.1%Hematology & Oncology Physic…0.1%
Largest specialties in Indiana (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

7979 N SHADELAND AVE STE 200
Indianapolis, IN 46250

Provider Details

NPI 1538508965
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 06/19/2013

Hospital and facility affiliations

Facilities where Daniel Sonnenburg, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Community Physician Network Specialty Care LLC
Indianapolis, IN
Community Physicians OF Indiana Inc
Indianapolis, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Sonnenburg, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$9.2K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

Daniel Sonnenburg, M.D. - brand share 38.0%
Hematology & Oncology Physician average

38% brand-name claims vs 62% generic, on 1,574 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,574
Total Claims
$5.8M
Total Drug Cost
307
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,015.033
Total Day Supply
49,604
Brand vs Generic
38% brand / 62% generic
Brand Drug Cost
$5.1M
Generic Drug Cost
$700K
Opioid Claims
46 (2.9% rate)
Antibiotic Claims
18

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
2.27
Gender Split
46% female / 54% male
Age Distribution
<65: 23, 65-74: 145, 75-84: 111, 85+: 28

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Daniel Sonnenburg, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Orgovyx
Relugolix
137
Prochlorperazine Maleate
127
Dexamethasone
123
Ondansetron Hcl
123
Prednisone
98
Abiraterone Acetate
90
Lynparza
Olaparib
84
Nubeqa
Darolutamide
70
Xarelto
Rivaroxaban
62
Eliquis
Apixaban
55

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Daniel Sonnenburg, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Daniel Sonnenburg, M.D.'s 1,574 claims are above the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Sonnenburg, both outside Indiana so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2013)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology & Oncology Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Sonnenburg.

One of 176 Hematology & Oncology Physician providers enrolled in Indiana, 5 are shown here.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Daniel Sonnenburg, M.D.'s specialty?
Daniel Sonnenburg, M.D. specializes in Hematology & Oncology Physician and practices in Indianapolis, Indiana. Credentials: M.D..
How much does Daniel Sonnenburg, M.D. prescribe under Medicare Part D?
In 2024, Daniel Sonnenburg, M.D. wrote 1,574 Medicare Part D claims totaling $5.8M in drug costs for 307 beneficiaries.
Where is Daniel Sonnenburg, M.D. located?
Daniel Sonnenburg, M.D. is located at 7979 N SHADELAND AVE STE 200, Indianapolis, IN, 46250. Phone: (317) 621-4300.
What is Daniel Sonnenburg, M.D.'s NPI number?
Daniel Sonnenburg, M.D.'s National Provider Identifier (NPI) is 1538508965, issued on 06/19/2013.
Does Daniel Sonnenburg, M.D. prescribe more brand-name or generic drugs?
Daniel Sonnenburg, M.D.'s prescribing is 38% brand-name and 62% generic drugs by claim count, with $5.1M in brand drug costs.
Does Daniel Sonnenburg, M.D. prescribe opioids?
Yes, Daniel Sonnenburg, M.D. had 46 opioid claims in 2024 with an opioid prescribing rate of 2.9%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Daniel Sonnenburg, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Daniel Sonnenburg, M.D.'s most frequently prescribed drugs include Orgovyx, Prochlorperazine Maleate, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Sonnenburg, M.D. accept Medicare?
Daniel Sonnenburg, M.D. appears in CMS Medicare data with 1,574 Part D claims and 307 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Sonnenburg, M.D.'s credentials?
Daniel Sonnenburg, M.D.'s NPI is 1538508965 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.